The Global Stem Cell Therapy Market is set to witness a healthy growth rate of 20% by 2029. A favorable investment ...

Osteogenic differentiation is essential for bone development, metabolism, and repair; however, the underlying regulatory relationships among genes remain poorly understood. To elucidate the ...

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

The advent of induced pluripotent stem cells (iPSCs) could be key to addressing this challenge, with iPSCs offering the potential for self-renewal and pluridirectional differentiation. iPSCs can ...

Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...

The Company has been selected to provide an oral presentation featuring clinical data from its ongoing Phase 1 clinical trial of FT819, its off-the-shelf, CD19-targeted, 1XX CAR T-cell product ...

This poster presents a feeder-free protocol that enables scalable differentiation of iPSCs into CD8+ single-positive ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...

A cell therapy for regenerating broken spinal cord using lab-grown neurons enters human trials for the first time.

Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...

The latest imaging method from the Broad Institute uncovers structural disruptions in the nucleus associated with progeria at super-resolution.

BACKGROUND: Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation ...